MEDIPOST (Korea) Top Management
078160 Stock | KRW 12,350 380.00 3.17% |
MEDIPOST employs about 267 people. The company is managed by 14 executives with a total tenure of roughly 77 years, averaging almost 5.0 years of service per executive, having 19.07 employees per reported executive. Analysis of MEDIPOST's management performance can provide insight into the company performance.
Yun Yang CEO Chief Executive Officer, Director |
Won Oh President Vice President Director |
MEDIPOST |
MEDIPOST Management Team Effectiveness
The company has return on total asset (ROA) of (0.0113) % which means that it has lost $0.0113 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.8711 %, meaning that it generated $1.8711 on every $100 dollars invested by stockholders. MEDIPOST's management efficiency ratios could be used to measure how well MEDIPOST manages its routine affairs as well as how well it operates its assets and liabilities.MEDIPOST Workforce Comparison
MEDIPOST Co is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 3,820. MEDIPOST holds roughly 267 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07. MEDIPOST Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. MEDIPOST Price Series Summation is a cross summation of MEDIPOST price series and its benchmark/peer.
MEDIPOST Notable Stakeholders
A MEDIPOST stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MEDIPOST often face trade-offs trying to please all of them. MEDIPOST's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MEDIPOST's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Yun Yang | Chief Executive Officer, Director | Profile | |
Won Oh | Vice President Director | Profile | |
Dong Hwang | President Director | Profile | |
Jang Lee | Vice President Director | Profile | |
Jin Kim | Director | Profile | |
Hyeon Min | Non-Executive Independent Director | Profile | |
Hong Kim | Director | Profile | |
JangWon Lee | Sr Director | Profile | |
YoungHwan Song | Head Director | Profile | |
YoonSeon Yang | CEO Pres | Profile | |
HyeKyung Hong | Director Director | Profile | |
WonII MD | VP Laboratory | Profile | |
SungHo Han | Head Director | Profile | |
SooJin MD | Director Director | Profile |
About MEDIPOST Management Performance
The success or failure of an entity such as MEDIPOST often depends on how effective the management is. MEDIPOST management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MEDIPOST management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MEDIPOST management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea. MEDIPOST is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of MEDIPOST's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEDIPOST's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MEDIPOST's management manipulating its earnings.
MEDIPOST Workforce Analysis
Traditionally, organizations such as MEDIPOST use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MEDIPOST within its industry.MEDIPOST Manpower Efficiency
Return on MEDIPOST Manpower
Revenue Per Employee | 205.5M | |
Revenue Per Executive | 3.9B | |
Net Loss Per Employee | 3.6M | |
Net Loss Per Executive | 69M | |
Working Capital Per Employee | 89.9M | |
Working Capital Per Executive | 1.7B |
Complementary Tools for MEDIPOST Stock analysis
When running MEDIPOST's price analysis, check to measure MEDIPOST's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIPOST is operating at the current time. Most of MEDIPOST's value examination focuses on studying past and present price action to predict the probability of MEDIPOST's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIPOST's price. Additionally, you may evaluate how the addition of MEDIPOST to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |